title: Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.
authors.forename: Y
authors.initials: Y
authors.lastname: Xu
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: Y
authors.initials: Y
authors.lastname: Zhao
authors.forename: L
authors.initials: L
authors.lastname: Zhao
authors.forename: H
authors.initials: H
authors.lastname: Qiu
authors.forename: D
authors.initials: D
authors.lastname: Wu
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D003029:Coagulants / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000379:methods; D015942:Factor VIIa / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003029:Coagulants; D007155:Immunologic Factors; D011994:Recombinant Proteins; D000069283:Rituximab; C103587:recombinant FVIIa; D015942:Factor VIIa